Popular weight-loss drugs linked to cognitive benefits but may pose kidney risks

by

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.

Leave A Comment

Your email address will not be published. Required fields are marked *